NEWS

From July 9 to 11, the Interphex Japan exhibition was held in grand fashion in Tokyo, drawing global pharmaceutical manufacturers and exhibitors to explore future-ready solutions and drive the development of the pharmaceutical industry.

From July 8 to 10, analytica Lab Africa was held at the Gallagher Exhibition Centre in Johannesburg. At this major event showcasing cutting-edge technologies, Haier Biomedical presented over ten advanced products — including incubator agitator for platelet, cryovial transfer flask, liquid nitrogen tank, and blood refrigerator — demonstrating to African and global biomedical industry partners the innovative capabilities of Chinese technology in improving laboratory efficiency and safeguarding life and health, offering new solutions to support the development of healthcare across  Africa.

On June 26, Haier Biomedical delivered its first batch of sterile isolators to Phenikaa University Hospital in Vietnam, marking the product's debut in the international market. With this delivery, the hospital's portfolio of high-end medical equipment has now been fully upgraded to Haier Biomedical solutions, including its biosafety cabinets, ultra-low temperature freezers, and blood refrigerators. 

Haier Biomedical recently welcomed a delegation from Vietnam's VH elite team, deepening their strategic partnership through a focused training program on core medical products and after-sales services.

On June 24, 2025, Haier Biomedical won the bid for a project with the Stem Cell Research Institute, a leading-edge biotechnology company in South Korea. The company completed a one-time delivery of 88 units of equipment, ranging from cryogenic storage systems to laboratory apparatus. This not only marks Haier Biomedical's debut in the Korean pharmaceutical market but also its step forward in expanding its presence in the international market through its innovative service model.

Haier Biomedical's CO₂ incubators are emerging as a top choice for research laboratories and universities across Hong Kong and Macao, thanks to its precision engineering and reliable performance. The equipment has been adopted by leading institutions, including the Department of Surgery at the University of Hong Kong (HKU), the School of Biomedical Sciences at the Chinese University of Hong Kong, and private testing laboratories in Macao. It is also used at the Jockey Club Interdisciplinary Research Building under HKU's Department of Chemistry. Across the board, users have responded with high praise.

On June 24, at the CPHI China 2025, HB TempCon Aviation — a subsidiary incubated by Haier Biomedical under Incaier — signed a strategic cooperation agreement with CEVA Logistics. The two sides will collaborate closely on expanding the global footprint of pharmaceutical cold chain logistics. Through shared resources and technological innovation, the partnership aims to significantly improve the efficiency and reliability of cross-border medical supply transportation, providing strong momentum for strengthening the resilience of the global pharmaceutical supply chain.

On June 17, 2025, Haier Biomedical, in partnership with UNICEF, conducted a specialized training session for technical personnel from Madagascar's Ministry of Health. The session focused on the operation of vaccine cold storage equipment and the Lora temperature monitoring system, advancing the country's vaccine cold chain infrastructure toward greater intelligence and precision.

Haier Biomedical's -86ºC ULT freezers, biosafety cabinets, centrifuges, and other flagship products have earned the trust of laboratories at the University of Sydney, recognized for their reliable performance in critical areas such as cryogenic storage and biological sample preservation. These technologies have helped drive breakthroughs and advance life science research at the university.